Olema Finance VP Buys 11,700 Shares at Zero Cost—Insider Bullish Signal
Insider buying at Olema’s finance VP signals confidence ahead of OPERA‑01, with executives buying zero‑price shares and analysts boosting sentiment.
3 minutes to read
Olema Pharmaceuticals Inc
Olema Pharma’s Big Insider Option Deal Signals Confidence—and Risks for Investors
Olema Pharmaceuticals’ new executive stock‑option grant signals confidence in its women’s oncology pipeline, offering upside potential but raising dilution concerns for investors.
5 minutes to read
Shane Kovacs Sells 3,822 Shares of Olema Pharma After JPMC Conference – What It Means for Investors
Insider sale of 3,822 Olema shares by COO Shane Kovacs: routine liquidity event amid JPMC buzz, fast‑track pipeline and bullish market backdrop.
3 minutes to read
Olema Insider Sell‑Off: What It Signals for Investors Amid Pipeline Uncertainty
Insider selling at Olema Pharmaceuticals signals a hedge‑strategy, not a crash; investors should weigh the biotech’s women’s‑cancer pipeline, market rally, and future trials before acting.
3 minutes to read